{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Chen L-p"],"funding":["Shanghai Collaborative Innovation Center for Chronic Disease Prevention and Health Services","Science and Technology Innovation Teams of Shanxi Province","MOST | National Natural Science Foundation of China (NSFC)","Local Colleges Faculty Constitution of Shanghai MSTC","MOST | National Natural Science Foundation of China"],"pagination":["e0197923"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11237417"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["12(6)"],"pubmed_abstract":["Numerous studies have supported that nonalcoholic fatty liver disease (NAFLD) is highly associated with gut microbiota dysbiosis. Ling-Gui-Zhu-Gan decoction (LG) has been clinically used to treat NAFLD, but the underlying mechanism remains unknown. This study investigated the therapeutic effect and mechanisms of LG in mice with NAFLD induced by a high-fat diet (HD). An HD-induced NAFLD mice model was established to evaluate the efficacy of LG followed by biochemical and histopathological analysis. Metagenomics, metabolomics, and transcriptomics were used to explore the structure and metabolism of the gut microbiota. LG significantly improved hepatic function and decreased lipid droplet accumulation in HD-induced NAFLD mice. LG reversed the structure of the gut microbiota that is damaged by"],"journal":["Microbiology spectrum"],"pubmed_title":["Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota."],"pmcid":["PMC11237417"],"funding_grant_id":["82004149","2021 Science and Technology 02-37","22010504300","82274213","202204051001030","81973730"],"pubmed_authors":["Hua H","Chen L-p","Zhang L-f","Liu B-c","Wang R-r","Liu S","Zhang L"],"additional_accession":[]},"is_claimable":false,"name":"Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota.","description":"Numerous studies have supported that nonalcoholic fatty liver disease (NAFLD) is highly associated with gut microbiota dysbiosis. Ling-Gui-Zhu-Gan decoction (LG) has been clinically used to treat NAFLD, but the underlying mechanism remains unknown. This study investigated the therapeutic effect and mechanisms of LG in mice with NAFLD induced by a high-fat diet (HD). An HD-induced NAFLD mice model was established to evaluate the efficacy of LG followed by biochemical and histopathological analysis. Metagenomics, metabolomics, and transcriptomics were used to explore the structure and metabolism of the gut microbiota. LG significantly improved hepatic function and decreased lipid droplet accumulation in HD-induced NAFLD mice. LG reversed the structure of the gut microbiota that is damaged by","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Jun","modification":"2026-03-17T16:14:03.07Z","creation":"2025-04-04T03:24:41.797Z"},"accession":"S-EPMC11237417","cross_references":{"pubmed":["38647315"],"doi":["10.1128/spectrum.01979-23"]}}